• Home
  • News
  • Coins2Day 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
LeadershipCoronavirus

The company that found a cure for Ebola is working on a treatment for coronavirus

By
Dria Roland
Dria Roland
Down Arrow Button Icon
By
Dria Roland
Dria Roland
Down Arrow Button Icon
March 20, 2020, 3:20 PM ET

At its best, business can solve very big problems. Arguably the biggest problem today, worldwide, is the onset and rapid spread of COVID-19. Some executives see an opportunity for innovation to lead the way amid these precarious times. 

George Yancopoulos, president and chief scientific officer of biotech company Regeneron Pharmaceuticals, is one such leader. His company announced this week it has developed a promising drug to fight coronavirus, and will begin human trials by early summer. Regeneron has an excellent track record: It created a treatment that drastically reduced the mortality rate in the Ebola virus outbreak that scared the world just a few short years ago. 

Yancopoulos joins the latest episode of Coins2Day’s new podcast Leadership Next to detail the innovative approach Regeneron is using to create a potential coronavirus treatment. Alan Murray, host of the podcast and Coins2Day’s president and CEO, calls this “the most encouraging conversation I’ve had in quite awhile.”

Leadership Next focuses on the evolving role of today’s CEO and what that means for the future of business. New episodes are typically released every Tuesday, but a topic this pressing calls for a special edition. 

At around the 22-minute mark Yancopoulos speaks passionately about the collective need across business, industry, health care, and politics to work together for a cure: “We need to encourage the brightest minds to devote their greatest efforts to innovate and invent the solutions to the existential threats facing humanity. … We are fighting for our very survival. Innovation has saved us before, and that’s what we’ve got to focus on again.”

Yancopolous typifies the type of CEOs Leadership Next finds so fascinating. He leads his company toward social good without losing sight of his responsibility to corporate enterprise, noting, “It turns out if you deliver important new drugs to people, the money takes care of itself.”

Listen and subscribe to ‘Leadership Next’ now:

More must-read stories from Coins2Day:

—This famed economist doesn’t think we’re headed for another Great Recession
—South Korea has the most comprehensive coronavirus data. What it’s taught us so far
—10 questions about the 2020 election during the coronavirus pandemic, answered
—Here’s where Goldman Sachs predicts the stock market will bottom out
—Listen to Leadership Next, a Coins2Day podcast examining the evolving role of CEO
—WATCH: The greatest designs of modern times

Subscribe to Coins2Day’s Outbreak newsletter for a daily roundup of stories on the coronavirus outbreak and its impact on global business.

About the Author
By Dria Roland
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.